ABVC · Abvc Biopharma, Inc. · Documents
$0.93
+0.02 (+2.20%)
At close · Oct 20
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“For the six months ended June 30, 2026, the Company reported net loss of $2,500,418. As of June 30, 2026, the Company's working capital deficit was $5,282,776. In addition, the Company had net cash outflows of $1,138,656 from operating activities for the six months ended June 30, 2026. These conditions give rise to substantial doubt as to whether the Company will be able to continue as a going concern.”View the 10-Q filed Aug 12, 2026
Market Cap
$25.59M
Shares
26.65M
Volume · Oct 20
11.82K
Avg daily vol (3M)
104.5K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2024-07-23 | — | |
| 8-K | — | 2024-07-12 | — | |
| 8-K/A | — | 2024-06-25 | 2023-11-16 | |
| 8-K/A | — | 2024-06-24 | 2024-03-26 | |
| S-1 | — | 2024-06-21 | — | |
| 8-K | — | 2024-05-24 | — | |
| 8-K | — | 2024-05-23 | — | |
| 10-Q | — | 2024-05-17 | 2024-03-31 | |
| 8-K/A | — | 2024-05-17 | 2024-02-08 | |
| 8-K | — | 2024-05-15 | — | |
| NT 10-Q | — | 2024-05-15 | 2024-03-31 | |
| 8-K | — | 2024-05-09 | — | |
| PRE 14A | — | 2024-04-26 | — | |
| 8-K | — | 2024-04-19 | — | |
| 8-K | — | 2024-04-17 | — | |
| 8-K | — | 2024-03-26 | — | |
| DEFA14A | — | 2024-03-25 | — | |
| S-1/A | — | 2024-03-22 | — | |
| 10-K/A | — | 2024-03-15 | 2023-12-31 | |
| 8-K | — | 2024-03-14 | — | |
| DEFA14A | — | 2024-03-14 | — | |
| 8-K | — | 2024-03-14 | — | |
| 10-K | — | 2024-03-13 | 2023-12-31 | |
| 8-K/A | — | 2024-02-29 | 2024-01-16 | |
| 8-K/A | — | 2024-02-29 | 2023-11-20 | |
| S-1/A | — | 2024-02-16 | — | |
| S-1/A | — | 2024-02-09 | — | |
| 8-K | — | 2024-02-08 | — | |
| 8-K/A | — | 2024-01-26 | 2023-11-16 | |
| 8-K | — | 2024-01-17 | 2024-01-16 | |
| 8-K | — | 2024-01-17 | — | |
| 8-K/A | — | 2024-01-17 | 2023-11-20 | |
| S-1 | — | 2024-01-12 | — | |
| DEF 14A | — | 2023-12-29 | 2024-01-16 | |
| PRE 14A | — | 2023-12-15 | — | |
| 8-K | — | 2023-11-20 | — | |
| 8-K | — | 2023-11-16 | — | |
| 10-Q | — | 2023-11-15 | 2023-09-30 | |
| 8-K | — | 2023-11-15 | — | |
| NT 10-Q | — | 2023-11-14 | 2023-09-30 | |
| 8-K | — | 2023-09-13 | — | |
| 8-K/A | — | 2023-09-06 | 2023-08-17 | |
| 8-K | — | 2023-08-31 | — | |
| 8-K | — | 2023-08-17 | 2023-08-14 | |
| 10-Q | — | 2023-08-14 | 2023-06-30 | |
| 8-K/A | — | 2023-08-09 | 2022-08-22 | |
| 8-K | — | 2023-08-07 | — | |
| 8-K | — | 2023-08-02 | — | |
| 8-K | — | 2023-07-31 | — | |
| 8-K | — | 2023-07-27 | — |
Showing 51–100 of 181 filings